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including immune defense in mammals and plants, patho-
gen virulence, sperm maturation and fertilization, venom 
toxicity, and prostate and brain cancer. Named after the 
founding members of this protein superfamily (cysteine-rich 
secretory protein, antigen 5, and pathogenesis-related 1), 
the CAP superfamily comprises more than 4,500 members 
in over 1,500 species, and family members are present in all 
kingdoms of life. Almost all CAP proteins are secreted gly-
coproteins and they are stable in the extracellular space 
over a wide range of conditions. All members of this super-
family share a common CAP domain of approximately 150 
amino acids, which adopts a unique   -  -  sandwich fold. 
The structural conservation of this domain suggests that 
CAP proteins exert a fundamentally similar function. The 
molecular mode of action of the CAP proteins, however, 
has remained enigmatic [for reviews see ( 1, 2 )]. 
 CAP proteins share limited sequence identity with each 
other and are characterized by two PROSITE-recognized 
sequence motifs, referred to as the CRISP family signature 
(shaded boxes in  Fig. 1 ). An early comparison of the struc-
ture of the plant pathogenesis-related protein (PR)-1 with 
that of the human glioma pathogenesis-related protein 1 
(GLIPR1) revealed that the small and structurally con-
served 17–21 kDa CAP domain adopts a unique   -  -  
sandwich fold, in which a three-stranded anti-parallel 
  -sheet is ﬂ anked by three helices on one side, and a fourth 
helix on the other ( 3 ). This three-stacked layer is stabi-
lized by hydrophobic interactions, multiple hydrogen bonds, 
and by two highly conserved disulﬁ de bonds. These fea-
tures are thought to provide the thermal, pH, and prote-
olytic stability required for the extracellular function of 
these proteins ( 3, 4 ). The CAP domain harbors four highly 
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phenotype of cells lacking Pry function, and the CAP do-
main of Pry1 alone binds sterols in vitro. This protein-lipid 
interaction is speciﬁ c, as it is lost when a highly conserved 
cysteine residue that is known to form a disulﬁ de bridge is 
mutated to serine. The lipid-binding and export function 
of the Pry proteins appears to be a conserved function of 
the members of the CAP protein superfamily, because ex-
pression of the human CAP protein, CRISP2, relieves the 
lipid export block of a yeast mutant lacking Pry function, 
and the puriﬁ ed CRISP2 binds sterols in vitro ( 10, 11 ). 
 The aim of the current study was to perform a structure-
function analysis of the yeast Pry1 protein to begin to de-
ﬁ ne the mode of sterol binding of this CAP superfamily 
member. Based on molecular modeling, site-directed mu-
tagenesis was employed to identify elements within the 
CAP domain of Pry1 that are important for lipid binding. 
 METHODS 
 Yeast strains, growth conditions, and epitope tagging 
 Yeast mutant strains were cultivated either in rich media, YPD 
(containing 1% Bacto yeast extract, 2% Bacto peptone, and 2% 
glucose; US Biological, Swampscott, MA) or in minimal deﬁ ned 
media (containing 0.67% yeast nitrogen base without amino 
acids (US Biological), 0.73 g/l amino acids, and 2% glucose). 
Media supplemented with sterols and fatty acids contained 0.05 
mg/ml Tween 80 and 20   g/ml cholesterol (Sigma Chemical 
Co., St. Louis, MO). To bypass heme deﬁ ciency, cells were grown in 
media supplemented with 10   g/ml delta-aminolevulinic acid. 
 Site-directed mutagenesis and Western blotting 
 Site-directed mutagenesis was performed using PCR fusion 
cassettes as described previously ( 12 ). Protein concentration was 
conserved partially surface-exposed residues, two histi-
dines, and two glutamic acid residues ( Fig. 1 ) ( 3 ). 
 These surface residues were suggested to adopt a confor-
mation similar to the active site histidyl and glutamyl residues 
of several Zn-dependent proteases and were suggested to 
form part of a putative active site triad of a CAP protein with 
a reported in vitro protease activity, Tex31 ( 5, 6 ). Apart from 
a possible catalytic activity of CAP family members, the CAP 
domain has been suggested to form a stable scaffold for bio-
logical interactions with other proteins ( 7 ). Although a large 
number of proteins within the superfamily contain a CAP do-
main in isolation (e.g., antigen 5 and PR-1), many others con-
tain additional N- or C-terminal extensions ( 2 ). 
 For example, CAP proteins harboring a C-terminal 
cysteine-rich domain, the deﬁ ning feature of the CRISP 
subfamily, have been associated with modulation of the ac-
tivity of ion channels, which might account for their role 
in sperm maturation and venom toxicity ( 6, 8, 9 ). How-
ever, whether the cysteine-rich domain of CRISP proteins 
acts directly on the ion channel or whether these proteins 
affect the channel’s activity more indirectly, for example 
through modulation of the lipid composition of the plasma 
membrane, remains to be established. 
 The genome of  Saccharomyces cerevisiae contains three 
CAP superfamily members, pathogen-related yeast (Pry)1, 
-2, and -3, named after their homology to the plant PR-1. 
We have recently shown that in yeast, these proteins are 
required for the export of cholesteryl acetate in vivo and 
that the puriﬁ ed proteins bind sterols in vitro ( 10 ). The 
sterol binding and export function of the yeast Pry1 is con-
ﬁ ned to the CAP domain, because expression of the CAP 
domain alone is sufﬁ cient to rescue the sterol export 
 Fig.  1. Sequence alignment of CAP superfamily members. Shown is a sequence alignment of human GLIPR2, 
yeast Pry1, and tomato PR1B1. The secondary structure elements within the CAP domain are indicated and the 
two CRISP family signatures are shaded. The cysteine residues forming the two conserved disulﬁ de bridges 
are marked in red and the conserved surface-exposed putative active site histidine and serine residues are 
marked in blue. 
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domain of the yeast Pry1 protein (residues 160-299) using 
the two closest ortholog proteins with structural data 
available as templates, human GLIPR2 [protein data base 
(PDB): 1SMB, X-ray structure at 1.55 Å resolution ( 15 )] 
and tomato PR1B1 [PDB: 1CFE, NMR structure ( 4 )]. 
These proteins display 39.5 and 32.9% sequence identity 
with the CAP domain of Pry1, respectively, and therefore 
can be used as reliable templates for homology modeling 
( Fig. 1 ). Two hundred different models were generated 
with MODELLER and the one with the lowest value for the 
discrete optimized energy (DOPE) score was used as a 
model for Pry1 ( 16 ). In this model, the positions of the   
helices and   sheet agree with independent secondary 
structure predictions, and the four conserved cysteine resi-
dues appear to form disulﬁ de bridges that help to stabilize 
the CAP domain, as was observed in the structure of the 
tomato PR1B1 ( Fig. 2A ) ( 4 ). 
 Structural analysis of yeast Pry1 
 Analysis of the model of the yeast protein, however, did 
not reveal a potential hydrophobic pocket that could ac-
commodate cholesterol, and all reported hydrophobic 
patches are buried inside the structure and not directly 
surface accessible, suggesting that cholesterol does not 
bind by simply sticking to a hydrophobic patch at the pro-
tein surface, but that binding of the lipid is likely accompa-
nied by signiﬁ cant structural rearrangement of the protein, 
as has been observed in other cholesterol binding proteins 
[e.g.,   -elicitin cryptogein ( 17 )]. To gain further insights 
into the possible mechanism of binding, we ﬁ rst analyzed 
the experimentally determined structural stability of hu-
man of GLIPR2, the closest ortholog of the yeast Pry1. The 
region displaying the largest b-factors corresponds to a 
loop (residues 89-101 of GLIPR2, corresponding to resi-
dues 236-248 of Pry1), which has homology to the caveolin-
binding motif ( Y N F QQPG F in GLIPR2,  Y D F SNPG F in 
Pry1). The human GLIPR2, also known as Golgi-associated 
PR-1 protein, GAPR1, is the only characterized intracellu-
lar CAP family member so far. GLIPR2 binds caveolin with 
a ﬂ exible loop that is rich in aromatic side chains (øxøxxxø, 
where ø is any aromatic side-chain), known as the caveolin-
binding motif ( 18, 19 ). This loop is remarkably conserved 
in mammals, ﬂ ies, worms, and fungi, but not in organisms 
such as plants, wasps, ants, or snakes ( Fig. 2B ). The con-
servation of this loop in ﬂ ies and fungi is particularly 
striking because caveolin is not present in these organ-
isms. The sequence of the loop harboring the caveolin-
binding motif in GLIPR2, however, is poorly conserved in 
the tomato PR1B1, displays ﬂ exibility in the NMR struc-
ture of this protein (PDB: 1CFE), and is signiﬁ cantly dis-
placed compared with that of the human GLIPR2 [root 
mean square deviation (RMSD) = 5.8 Å between residues 
89-101 in GLIPR2 and residues 101-115 in PR1B1 for the 
ﬁ rst NMR conformation]. Moreover, the conformation of 
this loop in PR1B1 appears to be stabilized by an addi-
tional disulﬁ de bridge, which is not present in the yeast or 
human homologs. The predicted structural ﬂ exibility of 
this loop and its relative low conservation in CAP family 
members of plants or toxin-producing reptiles and insects 
determined by Lowry assay using Folin reagent and BSA as stan-
dard. To analyze protein secretion into the culture supernatant, 
total proteins were extracted from three optical density at 600 nm 
(OD 600nm ) units of cells and from 10 ml of culture supernatant as 
previously described ( 10 ). Proteins were precipitated with 10% 
TCA, solubilized in sample buffer, and separated by SDS-PAGE. 
Western blotting was performed using rabbit antisera against 
GST (1:3,000; Bethyl Laboratories, Inc., Montgomery, TX) and 
Wbp1 (1:1,000; M. Aebi, ETH Zurich, Switzerland). 
 Lipid labeling and analysis 
 Acetylation and export of sterols into the culture supernatant 
were examined as described previously ( 13 ). Yeast mutants deﬁ -
cient in heme biosynthesis ( hem1  ) were cultivated in the pres-
ence of cholesterol/Tween-80-containing media and labeled 
with 0.025   Ci/ml [ 14 C]cholesterol (American Radiolabeled 
Chemicals, Inc., St. Louis, MO). Cells were harvested by centrifu-
gation, washed twice with synthetic complete (SC) media, diluted 
to an OD 600 of 1 into fresh media containing nonradiolabeled 
cholesterol, and grown overnight. Cells were centrifuged and lip-
ids were extracted from the cell pellet and the culture superna-
tant using chloroform/methanol (v/v, 1:1). Samples were dried 
and separated by TLC using silica gel 60 plates (Merck, Darmstadt, 
Germany) and using the solvent system petroleum ether/diethyl 
ether/acetic acid (70:30:2; per vol). Radiolabeled lipids on the 
TLC were quantiﬁ ed by scanning with a Berthold Tracemaster 40 
automatic TLC-linear analyzer (Berthold Technologies, Bad 
Wildbad, Germany). TLC plates were then exposed to phospho-
rimager screens and radiolabeled lipids were visualized using a 
phosphorimager (Bio-Rad Laboratories, Hercules, CA). 
 Expression and puriﬁ cation of wild-type and mutant 
versions of Pry1 
 DNA encoding wild-type and mutant versions of Pry1 was PCR 
ampliﬁ ed and subsequently cloned into the  NcoI and  XhoI sites of 
pET22b vector (Novagen, Merck, Darmstadt, Germany), which con-
tains a  PelB signal sequence to direct the secretion of the expressed 
protein into the periplasmic space. The vector was transformed 
into  Escherichia coli BL21 and the protein was expressed as a poly-
histidine-tagged fusion after lactose induction and overnight 
growth of the bacteria at 24°C. Cells were harvested, lysed, and 
incubated with Ni-NTA beads (Qiagen, Hilden, Germany) as per 
the instructions of the manufacturer. Beads were washed and 
proteins were eluted with imidazole, concentrated, and quantiﬁ ed. 
 In vitro lipid binding assay 
 The radioligand binding assay was performed as described pre-
viously ( 10, 14 ). Puriﬁ ed protein (100 pmol) in binding buffer 
[20 mM Tris (pH 7.5), 30 mM NaCl, 0.05% Triton X-100] was in-
cubated with [ 3 H]cholesterol (50 pmol) for 1 h at 30°C. The pro-
tein was then separated from the unbound ligand by adsorption to 
Q-Sepharose beads (GE Healthcare, USA); beads were washed and 
the radioligand was quantiﬁ ed by scintillation counting. For com-
petition binding assays, unlabeled cholesterol or cholesteryl ace-
tate (50 pmol) was included in the binding reaction. To determine 
nonspeciﬁ c binding, the ion exchange beads were incubated in 
the absence of added protein or an excess of unlabeled cholesterol 
was added into the binding assay. Data were analyzed using PRISM 
software (GraphPad, San Diego, CA). 
 RESULTS 
 As a ﬁ rst step toward an understanding how the yeast 
CAP family member, Pry1, can bind a hydrophobic ligand 
such as cholesterol, we modeled the structure of the CAP 
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suggest that this loop may not play an important structural 
function, and that it could be displaced upon binding to 
caveolin or other potential ligands such as cholesterol or 
related small hydrophobic compounds. 
 Fig.  2. Structural model of the yeast Pry1 protein, conservation 
of the putative caveolin-binding loop, and model of sterol-binding. 
A: Homology model of yeast Pry1. Blue residues show the four con-
served cysteine residues forming two disulﬁ de bridges (yellow) within 
the CAP domain. The ﬂ exible loop harboring the caveolin-binding 
motif is shown in green. B: Sequence alignment of the caveolin-binding 
motif across different organisms. Aromatic residues (shown in yellow 
and orange) form the caveolin-binding motif. C: Structural model of 
a possible open-loop conformation that could accommodate molecules 
such as cholesterol. For illustration purposes, the cholesterol molecule 
(green) was manually positioned so as to ﬁ ll optimally the open cavity . 
 To examine this possibility, we used the MODELLER 
software to generate random conformations of the loop 
(2,000 in total). While complete sampling of the different 
loop conformations is not feasible due to the astronomical 
number of degrees of freedom of the problem, geometri-
cal observation of the different conformers suggests that 
some conformations may open a hydrophobic cavity with 
a size that could potentially accommodate a molecule such 
as cholesterol ( Fig. 2C ). Although we cannot exclude 
other modes of binding involving remodeling of other 
parts of the protein ( 20 ), the resulting one-to-one binding 
model is consistent with kinetic data indicating stoichio-
metric binding of cholesterol to Pry1 ( 10 ), as well as our 
mutagenesis analysis (see below). 
 Mutations in the caveolin-binding motif affect the in vivo 
sterol export function of Pry1 
 The model of sterol binding by Pry1 through displace-
ment of the caveolin-binding motif predicts that hydro-
phobic residues within this loop (residues 236-248 of Pry1) 
are important for interaction with the hydrocarbon ring of 
the sterol. To test the functional signiﬁ cance of these resi-
dues, key residues within this loop region were mutated 
(F239L, F244L, P242C, and A292C) ( Fig. 3a ). If choles-
terol binding is indeed dependent on the loop sequence, 
the ﬁ rst two mutations are expected to lower the afﬁ nity 
for cholesterol, while not dramatically affecting the overall 
protein stability, because the Phe to Leu substitution at 
these two positions maintains the hydrophobic character 
and possibly hydrophobic interactions at these positions. 
However, these substitutions may disrupt the conserved 
caveolin-binding motif (FxFxxxxF) present in the human 
and yeast sequences. The model therefore predicts that 
these two substitutions should display reduced cholesterol 
binding. The last two mutations (P242C and A292C), on 
the other hand, are expected to strongly affect the confor-
mation of the loop itself and may even prevent the correct 
folding of the protein by creating nonnative disulﬁ de 
bridges with other cysteines. Therefore they are expected 
to completely abolish sterol binding. 
 To test these predictions, the mutant versions of Pry1 
were expressed as GST-fusions in yeast and their in vivo 
functionality was assessed. All proteins bearing mutations 
in this ﬂ exible loop were expressed and secreted into the 
culture supernatant, as is the case for the wild-type protein 
( Fig. 3B ). These results indicate that these mutant versions 
are properly translocated into the endoplasmic reticulum 
lumen , packed into secretory vesicles, and secreted out of 
the cell. To test the in vivo sterol-binding and export func-
tion of the mutant proteins, cells were labeled with [ 14 C]
cholesterol and Pry1-dependent export of cholesteryl ace-
tate was assessed by extracting lipids from the cell pellet 
and the culture media of heme-deﬁ cient cells lacking the 
sterol deacetylase Say1 as well as the wild-type versions of 
Pry2 and Pry3. In these sterol export assays, heme-deﬁ cient 
cells need to be used to allow for uptake of the radiola-
beled cholesterol and deﬁ ciency of the deacetylase, Say1, 
is required to monitor accumulation and Pry-dependent 
export of cholesteryl acetate ( 10, 13 ). Lipids were separated 
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 Fig.  3. Mutations within the caveolin-binding motif abrogate the in vivo sterol-export function of Pry1. A: Structural model of Pry1. Resi-
dues within the loop region that were substituted are marked in green (F239, P242, F244, A292 ). B: Loop mutants are secreted. Cells ex-
pressing a GST-tagged wild-type or the indicated mutant versions of Pry1 were cultivated, proteins present in the cell pellet (P) and the 
culture supernatant (S) were TCA precipitated, separated by PAGE, and probed for the presence of the tagged protein and for Wbp1, an 
integral endoplasmic reticulum membrane protein and subunit of the oligosaccharyl transferase complex. C: Loop mutants are defective 
in export of cholesteryl acetate. Heme-deﬁ cient cells of the indicated genotype expressing a GST-tagged wild-type or mutant versions of 
Pry1 were radiolabeled with [ 14 C]cholesterol, washed, and chased with media containing unlabeled cholesterol; lipids were extracted from 
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the cell pellet (P) and the culture supernatant (S), and separated by TLC. The position of free cholesterol (FC), cholesteryl acetate (CA), 
and steryl esters (STE) is indicated on the right. Stars mark positions of unidentiﬁ ed cholesterol-derivatives. D: Quantiﬁ cation of the export 
of cholesteryl acetate. The export index indicates the relative percentages of cholesteryl acetate that are exported by the cells (ratio be-
tween the extracellular cholesteryl acetate and the sum of intra- and extracellular cholesteryl acetate). Data represent mean ± SD of two 
independent experiments. 
by TLC and radiolabeled sterol-derivatives were visualized 
by phosphorimaging and quantified by radioscanning 
( Fig. 3C ). This in vivo assay for lipid-binding of the loop 
mutants revealed that cells expressing the wild-type Pry1 
protein had a signiﬁ cant amount of their total cholesteryl 
acetate exported into the culture supernatant. All four 
mutant versions, however, failed to export signiﬁ cant 
amounts of cholesteryl acetate into the culture superna-
tant and thus were defective for export of cholesteryl ace-
tate ( Fig. 3C ). Quantiﬁ cation of the amount of cholesteryl 
acetate that was exported by the cells revealed that cells 
expressing the wild-type protein had about equal levels of 
intracellular cholesteryl acetate as they had cholesteryl ac-
etate exported into the culture supernatant, resulting in 
an export index of approximately 0.45 (calculated as the 
ratio between the extracellular cholesteryl acetate and the 
sum of intra- and extracellular cholesteryl acetate). The 
mutants however, had an export index of approximately 
0.05, indicating that they exported about 10-fold less cho-
lesteryl acetate than did a corresponding wild-type ( Fig. 3D ). 
Given that all the proteins are secreted, these results sug-
gest that the mutants have lost their capacity to bind the 
hydrophobic ligand, and thus, that residues within this 
loop region are functionally important for the lipid-bind-
ing activity of Pry1 in vivo. 
 Mutations in residues outside of the caveolin-binding 
motif do not affect the in vivo functionality of Pry1 
 All mutations in the caveolin-binding motif of Pry1 af-
fected its sterol export function in vivo. However, this ef-
fect could also arise from a global structural destabilization 
of the protein. We therefore selected other hydrophobic 
residues with similar surface exposure as F239 and F244, 
but located far away from the caveolin-binding motif, to 
test whether substitutions at these sites would also affect 
the functionality of the protein in vivo ( Fig. 4A ). Muta-
tions at these sites (L206V, L219A, F162L) are expected to 
have similar effects on the global structure of the protein, 
but will not affect the caveolin-binding motif containing 
loop. All three of these mutants were properly secreted 
and complemented the sterol export defect of a mutant 
lacking Pry function ( pry2  pry3  ), suggesting that these 
amino acid substitutions did not impact the in vivo sterol-
binding activity of Pry1 ( Fig. 4 ). 
 Substitutions of putative active site residues of Pry1 do 
not affect sterol-binding and export 
 A CAP family member from the venom duct of the cone 
snail, Tex 31, was shown to have proteolytic activity in vitro. 
The activity was inhibited by serine protease inhibitors and 
stimulated by Ca 2+ ( 5 ). Computational modeling of the 
Tex31 sequence to the structure of PR-1 and antigen 5 was 
consistent with a possible catalytic role of the conserved 
surface-exposed histidine and glutamic acid residues ( 5 ). 
The lack of a conserved serine in this putative active site 
led to the proposition that dimerization is required to 
complete the formation of an active site triad, characteris-
tic for enzymes belonging of the   /  hydrolase fold su-
perfamily ( 15 ). However, other studies failed to detect 
protease activity with puriﬁ ed CAP family members, and a 
conclusive demonstration of the protease activity for a 
mammalian, fungal, or plant CAP protein still remains to 
be provided ( 8, 21 ). 
 To examine whether these surface-exposed putative ac-
tive side residues, which are conserved in Pry1, are func-
tionally important for the sterol-binding activity of Pry1, 
we substituted H170, H250, and E233 to alanine ( Fig. 5A ). 
The resulting mutant versions were properly synthesized 
and secreted from the cells and all three mutations com-
plemented the sterol export defect of a yeast mutant lack-
ing Pry function, indicating that these putative active site 
residues are not crucial for the functionality of the protein 
in vivo ( Fig. 5 ) 
 Mutations in the caveolin-binding motif of Pry1 affect 
binding of cholesteryl acetate but not that of cholesterol 
 To examine whether the mutations in the caveolin-
binding domain, in unrelated hydrophobic residues, or 
those in putative active site residues affect the lipid bind-
ing properties of Pry1 in vitro, hexahistidine-tagged ver-
sions of these proteins were expressed in bacteria and 
puriﬁ ed by afﬁ nity chromatography. SDS-PAGE analysis of 
the puriﬁ ed proteins revealed a single Coomassie-stained 
band with an apparent molecular mass of approximately 
37 kDa (data not shown). 
 The sterol-binding capacity of the mutant versions was 
assessed by in vitro binding assays and plotted relative to 
that of wild-type Pry1 ( Fig. 6A ). This analysis revealed 
that all the mutations retained their ability to bind free cho-
lesterol. To examine why the mutations in the caveolin-
binding motif failed to complement the defect in export 
of cholesteryl acetate in vivo, we performed competition 
binding experiments in which cold cholesteryl acetate 
competes with [ 3 H]cholesterol for binding to the pro-
tein. These binding assays revealed that only the muta-
tions in the caveolin-binding site affected in vitro binding 
of cholesteryl acetate ( Fig. 6B ). To conﬁ rm these results 
we performed titration experiments to determine the rela-
tive afﬁ nity of some of the mutant proteins to cholesteryl 
acetate. The results of these experiments indicate that 
mutations in the caveolin-binding site selectively af-
fected binding of cholesteryl acetate, but not that of 
free cholesterol ( Fig. 7 ). Taken together, the results pre-
sented here are consistent with a role of the caveolin-
binding motif in selective lipid binding of Pry1 in vitro 
and in vivo. 
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 Fig.  4. Mutations in other hydrophobic residues do not affect export of cholesteryl acetate in vivo. 
A: Structural model of Pry1. The two residues within a common loop (L206, L219) and the one residue at 
the base of helix 1 (F162) that were substituted are indicated in blue . B: The mutants are all secreted. Cells 
expressing a GST-tagged wild-type or the indicated mutant versions of Pry1 were cultivated, proteins present 
in the cell pellet (P) and the culture supernatant (S) were TCA precipitated, separated by PAGE, and probed 
for the presence of the tagged protein and for Wbp1. C: Mutants are functional for export of cholesteryl 
acetate. Heme-deﬁ cient cells of the indicated genotype expressing a GST-tagged wild-type or mutant versions 
of Pry1 were radiolabeled with [ 14 C]cholesterol, washed, and chased with media containing unlabeled cho-
lesterol; lipids were extracted from the cell pellet (P) and the culture supernatant (S), and separated by 
TLC. The position of free cholesterol (FC), cholesteryl acetate (CA), and steryl esters (STE) is indicated on 
the right. Stars mark positions of unidentiﬁ ed cholesterol-derivatives. D: Quantiﬁ cation of the export of 
cholesteryl acetate. The export index indicates the relative percentages of cholesteryl acetate that is ex-
ported. Data represent mean ± SD of two independent experiments. 
7
ht
tp
://
do
c.
re
ro
.c
h
 Fig.  5. Mutations in putative active-site residues are functional for cholesteryl acetate export in vivo. A: Structural model of Pry1. Residues 
proposed to form part of a putative active site are indicated in blue (H170, E233, H250 ). B: Mutants in putative active site residues are se-
creted. Cells expressing a GST-tagged wild-type or the indicated mutant versions of Pry1 were cultivated, proteins present in the cell pellet 
(P) and the culture supernatant (S) were TCA precipitated, separated by PAGE, and probed for the presence of the tagged protein and for 
Wbp1. C: Mutants in putative active site residues are functional in export of cholesteryl acetate. Heme-deﬁ cient cells of the indicated geno-
type expressing a GST-tagged wild-type or mutant versions of Pry1 were radiolabeled with [ 14 C]cholesterol, washed, and chased with media 
containing unlabeled cholesterol; lipids were extracted from the cell pellet (P) and the culture supernatant (S), and separated by TLC. The 
position of free cholesterol (FC), cholesteryl acetate (CA), and steryl esters (STE) is indicated on the right. Stars mark positions of uniden-
tiﬁ ed cholesterol-derivatives. D: Quantiﬁ cation of the export of cholesteryl acetate. The export index indicates the relative percentages of 
cholesteryl acetate that is exported. Data represent mean ± SD of two independent experiments. 
 DISCUSSION 
 The data presented in this study indicate that the caveolin-
binding motif that is present in the yeast CAP superfamily 
member, Pry1, is important for the in vivo as well as the in 
vitro sterol binding activity of the protein. Analysis of 
known structures and homology modeling indicate that 
the loop region harboring this motif is one of the most 
ﬂ exible parts of the protein and may be displaced upon 
lipid binding. Point mutations within this motif selectively 
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their aromatic residues are buried within the protein and 
thus are unlikely to interact directly with caveolin ( 23 ). 
On the other hand, the caveolin-binding motif ﬁ rst de-
scribed for a CAP superfamily member, GLIPR2, has been 
shown to interact with caveolin by coimmunoprecipita-
tion after chemical crosslinking of proteins ( 18 ). In the 
context of yeast Pry1, the presence of the caveolin-binding 
motif is unlikely of relevance for a direct interaction be-
tween Pry1 and caveolin, because a homolog of caveolin is 
not detectable in the yeast genome and caveolae are not 
present in the plasma membrane of this fungus. Thus, we 
consider it more likely that the loop harboring this se-
quence motif in Pry1 requires the characteristic spacing 
of the aromatic side chains to exert its function in selec-
tive lipid binding, which, according to our computational 
modeling experiments, requires displacement of the loop 
and exposure of a hydrophobic cleft. Given that the 
substitutions of two of the aromatic residues within this 
motif by leucine (F239 and F244), an at least equally 
abrogate cholesteryl acetate binding without affecting 
binding of free cholesterol. Mutations outside the caveolin-
binding motif, either in distant hydrophobic amino acids 
with a similar role in protein stability or in putative active 
site residues, on the other hand, did not affect the func-
tionality of the protein in vivo, because cells expres sing 
these mutant versions were still capable of exporting cho-
lesteryl acetate, nor did they affect binding of free choles-
terol or cholesteryl acetate in vitro. 
 The caveolin-binding motif was originally uncovered by 
screening phage display peptides that bind to the caveolin-
scaffolding domain of caveolin, a coat protein required 
for formation of caveolae, small ﬂ ask-shaped pits of the 
plasma membrane of metazoan ( 19, 22 ). However, the 
caveolin-binding motif is a widespread sequence motif 
rich in aromatic residues, which is present in about 30% 
of human proteins ( 23 ). Recent analysis of the solvent 
accessible area of putative caveolin-binding motifs in pro-
teins of known structure indicates that, the majority of 
 Fig.  6. Mutations in the caveolin-binding motif affect cholesteryl acetate binding in vitro. A: In vitro cho-
lesterol binding of wild-type and mutant versions of Pry1. Sterol-binding was assessed in vitro using 100 pmol 
of the puriﬁ ed protein and 50 pmol of [ 3 H]cholesterol as ligand. The protein was separated from unbound 
ligand by adsorption to an anion-exchange matrix and bound radioligand was quantiﬁ ed by scintillation 
counting and blotted relative to that of the wild-type protein. B: In vitro ligand competition. Binding of [ 3 H]
cholesterol to wild-type and mutant versions of Pry1 was assessed as in (A) but in the presence of 50 pmol of 
unlabeled cholesteryl acetate. w/o CA, without cholesteryl acetate. Data represent mean ± SD of three inde-
pendent experiments . 
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considerably more hydrophobic than cholesterol, as indi-
cated by their different migration in the TLC systems in 
which cholesteryl acetate migrates much closer to the 
long-chain steryl esters (mostly cholesteryl palmitoleate) 
than to the free cholesterol. It thus diffuses more slowly 
through the aqueous space and requires a much longer 
time to reach binding equilibrium compared with free 
cholesterol, explaining why cholesteryl acetate does not 
compete for binding as efﬁ ciently as does a sterol with a 
free 3 ′ hydroxyl group. The fact that mutations in the 
caveolin-binding site selectively affect binding of the 
hydrophobic amino acid, abrogates binding of cholesteryl 
acetate indicates that the cleft does not only need to be 
hydrophobic but also that the aromatic character of the 
side chain is important. 
 The observation that mutations in the caveolin-binding 
site selectively affect binding of cholesteryl acetate is re-
markable. The fact that cholesteryl acetate competes with 
free cholesterol for binding to wild-type Pry1 indicates that 
the binding sites of these two ligands at least partially over-
lap and that only one of the two ligands can be stably 
bound to the protein at a given time. Cholesteryl acetate is 
 Fig.  7. Mutations in the caveolin-binding motif affect in vitro binding of cholesteryl acetate but not binding of free cholesterol. Binding 
of [ 3 H]cholesterol (50 pmol) to wild-type and mutant versions of Pry1 (100 pmol) was completed by addition of increasing concentrations 
of unlabeled free cholesterol or of cholesteryl acetate. Data represent mean ± SD of three independent experiments. 
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predicted signal sequence or conserved disulﬁ de bonds, 
but the protein is myristoylated and associates with the cy-
tosolic surface of the Golgi membrane ( 18 ). The non-
myristoylated protein binds to the surface of liposomes 
containing negatively charged lipids and this interaction is 
regulated by dimerization of the protein ( 30, 31 ). Interest-
ingly, the protein can bind up to three molecules of phos-
phatidylinositol tightly enough to resist denaturation or 
organic solvent extraction, which has led to the specula-
tion that it may form covalent bridges with the lipid ( 30 ). 
 While these data are all consistent with a function of 
CAP superfamily proteins in lipid binding, structural data 
to resolve the sterol binding site is now required to further 
understand the mode of action of these proteins.  
 The authors thank Dr. L. Falquet (University of Fribourg) for 
bioinformatics support and Dr. D. Kressler (University of Fri-
bourg) for access to his cell homogenizer . 
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